182 related articles for article (PubMed ID: 35965662)
1. Exploring SARS-CoV2 host-pathogen interactions and associated fungal infections cross-talk: Screening of targets and understanding pathogenesis.
Khan AA; Jain SK; Rai M; Panda S
Comput Struct Biotechnol J; 2022; 20():4351-4359. PubMed ID: 35965662
[TBL] [Abstract][Full Text] [Related]
2. Comparative Host-Pathogen Interaction Analyses of SARS-CoV2 and Aspergillus fumigatus, and Pathogenesis of COVID-19-Associated Aspergillosis.
Khan AA; Farooq F; Jain SK; Golinska P; Rai M
Microb Ecol; 2022 Nov; 84(4):1236-1244. PubMed ID: 34738157
[TBL] [Abstract][Full Text] [Related]
3. In silico strategies to identify protein-protein interaction modulator in cell-to-cell transmission of SARS CoV2.
Basu A; Sarkar A; Bandyopadhyay S; Maulik U
Transbound Emerg Dis; 2022 Nov; 69(6):3896-3905. PubMed ID: 36379049
[TBL] [Abstract][Full Text] [Related]
4. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.
Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar
Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721
[TBL] [Abstract][Full Text] [Related]
5. Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual.
Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M
bioRxiv; 2021 Feb; ():. PubMed ID: 33619483
[TBL] [Abstract][Full Text] [Related]
6. An in-silico approach to study the possible interactions of miRNA between human and SARS-CoV2.
Sarma A; Phukan H; Halder N; Madanan MG
Comput Biol Chem; 2020 Oct; 88():107352. PubMed ID: 32771962
[TBL] [Abstract][Full Text] [Related]
7. Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity.
Kumar S; Singh B; Kumari P; Kumar PV; Agnihotri G; Khan S; Kant Beuria T; Syed GH; Dixit A
Comput Struct Biotechnol J; 2021; 19():1998-2017. PubMed ID: 33841751
[TBL] [Abstract][Full Text] [Related]
8. A Paradigm Gap in Host-Pathogen Interaction Studies: Lesson from the COVID-19 Pandemic.
Pooranachithra M; Muthubharathi BC; Balamurugan K
Adv Exp Med Biol; 2021; 1353():47-70. PubMed ID: 35137367
[TBL] [Abstract][Full Text] [Related]
9. Comparative host-pathogen protein-protein interaction analysis of recent coronavirus outbreaks and important host targets identification.
Khan AA; Khan Z
Brief Bioinform; 2021 Mar; 22(2):1206-1214. PubMed ID: 32914167
[TBL] [Abstract][Full Text] [Related]
10. Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis.
Tarique M; Ahmad S; Malik A; Ahmad I; Saeed M; Almatroudi A; Qadah T; Murad MA; Mashraqi M; Alam Q; Al-Saleh Y
Mol Cell Biochem; 2021 May; 476(5):2203-2217. PubMed ID: 33564990
[TBL] [Abstract][Full Text] [Related]
11. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
Messina F; Giombini E; Agrati C; Vairo F; Ascoli Bartoli T; Al Moghazi S; Piacentini M; Locatelli F; Kobinger G; Maeurer M; Zumla A; Capobianchi MR; Lauria FN; Ippolito G;
J Transl Med; 2020 Jun; 18(1):233. PubMed ID: 32522207
[TBL] [Abstract][Full Text] [Related]
12. Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19).
Arora S; Singh P; Dohare R; Jha R; Ali Syed M
Gene; 2020 Dec; 762():145057. PubMed ID: 32805314
[TBL] [Abstract][Full Text] [Related]
13. Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach.
Batool A; Bibi N; Amin F; Kamal MA
Eur J Pharmacol; 2021 Feb; 892():173779. PubMed ID: 33275961
[TBL] [Abstract][Full Text] [Related]
14. Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses.
Pacheco Y; Valeyre D; El Jammal T; Vallee M; Chevalier F; Lamartine J; Sigaudo-Roussel D; Verrier B; Israel-Biet D; Freymond N; Cottin V; Calender A
Cells; 2021 Aug; 10(8):. PubMed ID: 34440765
[TBL] [Abstract][Full Text] [Related]
15. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
16. Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infection.
Barton MC; Bennett KV; Cook JR; Gallup GG; Platek SM
Med Hypotheses; 2020 Aug; 141():109750. PubMed ID: 32388138
[TBL] [Abstract][Full Text] [Related]
17. Comparative Genomics and Integrated Network Approach Unveiled Undirected Phylogeny Patterns, Co-mutational Hot Spots, Functional Cross Talk, and Regulatory Interactions in SARS-CoV-2.
Gupta V; Haider S; Verma M; Singhvi N; Ponnusamy K; Malik MZ; Verma H; Kumar R; Sood U; Hira P; Satija S; Singh Y; Lal R
mSystems; 2021 Feb; 6(1):. PubMed ID: 33622851
[TBL] [Abstract][Full Text] [Related]
18. Effects of SARS-CoV‑2 infections on inpatient mortality of geriatric patients after proximal femoral fracture surgery.
Zajonz D; Vaitl P; Edel M; Fuchs O; Kübler F; Schneider P; Roth A; Prietzel T
Orthopadie (Heidelb); 2022 Jul; 51(7):573-579. PubMed ID: 35776154
[TBL] [Abstract][Full Text] [Related]
19. Microbiota, probiotics and respiratory infections: the three musketeers can tip off potential management of COVID-19.
Khan AA; Singh H; Bilal M; Ashraf MT
Am J Transl Res; 2021; 13(10):10977-10993. PubMed ID: 34786037
[TBL] [Abstract][Full Text] [Related]
20. Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA.
Bello M; Martínez-Muñoz A; Balbuena-Rebolledo I
J Mol Model; 2020 Nov; 26(12):340. PubMed ID: 33184722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
